Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Concerta	-	-	-	-	[1] 203 💬
2	D-methylphenidate	Methylphenidate	[2] D01296, D04999 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle	[1] 84 💬
3	Methylphenidate	Methylphenidate	[2] D01296, D04999 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle	[7]  6 , 13, 34, 84, 113, 179, 206 💬
4	Methylphenidate (mpd)	Methylphenidate	[2] D01296, D04999 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle	[1]  6  💬
5	Methylphenidate (overencapsulated)	Methylphenidate	[2] D01296, D04999 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle	[1] 84 💬
6	Methylphenidate 10mg tablets	Methylphenidate	[2] D01296, D04999 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle	[1] 84 💬
7	Methylphenidate hydrochloride	Methylphenidate	[2] D01296, D04999 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle	[2]  6 , 13 💬
8	Methylphenidate modified release	Methylphenidate	[2] D01296, D04999 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle	[1] 13 💬
9	Methylphenidate modified release 20 mg	Methylphenidate	[2] D01296, D04999 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle	[1] 13 💬
10	Methylphenidate modified release 30 mg	Methylphenidate	[2] D01296, D04999 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle	[1] 13 💬
11	Methylphenidate modified release 40 mg	Methylphenidate	[2] D01296, D04999 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle	[1] 13 💬
12	Methylphenidate, fluoxetin, risperidone	Fluoxetine	[5] D00326, D00426, D00823, D01296, D04999 💬	[5] DRD2, HTR2A, SLC6A2, SLC6A3, SLC6A4 💬	[14] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway	[2] 179, 206 💬